| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $4.9M | +19.3% |
| SG&A Expense | $111.5M | +127.1% |
| Operating Income | -$122.7M | -125.2% |
| Interest Expense | $50.3M | — |
| Net Income | -$221.6M | -269.0% |
| EPS (Basic) | -$0.94 | -44.6% |
| EPS (Diluted) | -$0.94 | -44.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.2M | -39.1% |
| Current Assets | $314.5M | +391.9% |
| Total Assets | $3.32B | +963.9% |
| Current Liabilities | $552.4M | +2078.1% |
| Long-term Debt | $1.82B | — |
| Total Liabilities | $2.58B | +4545.0% |
| Stockholders' Equity | $287.9M | +429.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.6M | -83.7% |
| Capital Expenditures | $1.74B | +5048.1% |
| Investing Cash Flow | -$1.75B | -4186.8% |
| Financing Cash Flow | $2.06B | +1641.2% |
| Free Cash Flow | -$1.81B | -2353.3% |